Dikhyaa Mohanty 
The latest national sero survey has reported that over two-thirds of Indians (67.6%) have developed antibodies against COVID-19, the fourth such survey by the Indian Council of Medical Research (ICMR).
According to the reports, this also means that 40 crore people in India are still at risk and therefore a matter of concern. The sero survey was conducted in 70 districts across the country in June-July. As many as 28,975 participants were enrolled for the survey, including children of 6-17 years of age.
Director General (DG) of ICMR Dr Balram Bhargava stated that two-third of the general population had SARS-CoV-2 antibodies and a third of the population did not have antibodies, which means 40 crore people are still in the vulnerable category. The states and districts without antibodies run the risk of infection waves.
The report further added that as per the survey the overall sero-prevalence of India be 67.6% and more than half of the children between 6 and 17 years were found to be seropositive (having COVID antibodies).
